
- BioPharm International, May 2022 Issue
- Volume 35
- Issue 5
- Pages: 48
Rapid Mass Photometer
The SamuxMP enables routine quantification of empty/full AAV capsid ratios
Designed to be easy to use with only basic training, the SamuxMP
mass photometer is utilized in adeno-associated virus (AAV)
analytics. The instrument has a mass range tailored for AAV analysis and
provides accurate results in less than five minutes from sample loading to final result. Combined with low-operational costs and a small footprint, the SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization.
The SamuxMP is designed to overcome the drawbacks of the current analytical methods by enabling users to rapidly and cost- effectively determine empty/full capsid ratios for AAVs of any serotype at the bench using low sample volumes and concentrations with minimal sample preparation. This is intended to enhance productivity and speed up workflows through more frequent analyses in-house, making R&D and process development of gene therapies and AAV-based therapeutics significantly more efficient.
Articles in this issue
over 3 years ago
Emerging Therapies Face Development Hurdlesover 3 years ago
Emerging Plant-based Platform for Biomanufacturingover 3 years ago
An Evolving Approach to Drug Deliveryover 3 years ago
Addressing the Training Gap for Single-Use Technologiesover 3 years ago
A Robust Quality Culture Benefits Allover 3 years ago
Automating Cell Harvesting for Cell Therapiesover 3 years ago
Addressing Limitations of Sterility Testingover 3 years ago
Perspectives on Process Analytical Technologyover 3 years ago
Data Integrity as Current Good Manufacturing Practiceover 3 years ago
Using a Modeling Approach to Preclinical StudiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.